IDH1 p.R132H

Biomarker type: Somatic variant

Gene context: IDH1

HGVS.p: NP_005887.2:p.Arg132His

Precision oncology relationships for therapeutic response involving this biomarker.

Organizations	Biomarkers	Cancer types	Therapies
FDA (2)	IDH1 p.R132H	Acute Myeloid Leukemia	Ivosidenib
EMA (1) FDA (1)	IDH1 p.R132H	Acute Myeloid Leukemia	Azacitidine, Ivosidenib
FDA (1)	IDH1 p.R132H	Myelodysplastic Syndromes	Ivosidenib
EMA (1) FDA (1)	IDH1 p.R132H	Cholangiocarcinoma	Ivosidenib
FDA (1)	IDH1 p.R132H	Acute Myeloid Leukemia	Olutasidenib
EMA (1) FDA (1)	IDH1 p.R132H	Astrocytoma	Vorasidenib
EMA (1) FDA (1)	IDH1 p.R132H	Oligodendroglioma	Vorasidenib